National Law Journal Recognizes Wilkinson Walsh’s Industry-Leading Products Liability/Mass Tort Trial Practice

WASHINGTON – The National Law Journal selected Wilkinson Walsh as one of its Washington D.C. Litigation Departments of the Year in Products Liability/Mass Torts. NLJ’s selection was based on Wilkinson Walsh’s string of trial victories in high-profile products liability cases.  Most recently, the firm, led by Alex Walsh, Kieran Gostin, and James Rosenthal, won a decisive victory in Bayer v. Farar, a certified consumer class action trial involving $600 million in claimed damages. Previously, the firm reeled off five straight victories in the Xarelto products liability litigation, with Beth Wilkinson, Alex Walsh, Brian Stekloff, Jeremy Barber, Tamarra Matthews Johnson, and Rakesh Kilaru serving in lead roles. NLJ’s profile on the firm highlights commentary from Beth, Alex, and Brian on their strategy and approach to litigation. “We believe that at the heart of every case is a simple compelling narrative, a narrative that shows the jury why our side should prevail,” …

Wilkinson Walsh Continues Its Ascent in Chambers and Partners

Firm and Attorneys Moved Up the Ranks in 2020 WASHINGTON — Continuing its rapid rise, Wilkinson Walsh made a strong showing in the 2020 Chambers and Partners rankings.  Chambers recognized the firm as a litigation and products liability powerhouse, and also spotlighted three of the firm’s founding partners. In recognition of the firm’s track record of success in bet-the-company cases, Chambers moved Wilkinson Walsh up to Band 2 for General Litigation.  Additionally, for the first time, Wilkinson Walsh received recognition for success in Product Liability & Mass Torts. Chambers and Partners described Wilkinson Walsh as an “impressive litigation boutique, noted for its expert handling of complex, bet-the-company cases for leading corporate clients across a wide range of sectors, with a substantial market share in the pharmaceutical industry.” Chambers also praised Wilkinson Walsh’s “enviable bench,” including “several leading practitioners with significant federal prosecutorial and public defense experience,” as well as the …

Wilkinson Walsh Lawyers Named to Lawdragon 500 Leading Lawyers in America List

Washington – For the second year in a row, Partners Beth Wilkinson, Alexandra Walsh, Brian Stekloff, and Kosta Stojilkovic were named to Lawdragon 500’s list of the 500 Leading Lawyers in America. In its 15th year, the Lawdragon 500 comprises the top legal talent across the profession. Over the last year, all four attorneys have received accolades for their industry-leading accomplishments. For example, Alexandra was named a Law360 Trials MVP of the Year, Beth Wilkinson has received the Chambers USA Lifetime Achievement Award, Brian was named to Washingtonian Magazine’s top lawyers list, and Kosta was named to Benchmark Litigation’s 40 and Under Hot List. Founded in February 2016, Wilkinson Walsh has grown to nearly 45 lawyers and has quickly established itself as the leading boutique trial firm in the country. The firm has tried over a dozen cases to verdict across the country, winning the vast majority, and won several …

Wilkinson Walsh Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

WASHINGTON –Wilkinson Walsh enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Wilkinson Walsh Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

WASHINGTON – Wilkinson Walsh is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Walsh’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Walsh won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Walsh, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Walsh, led by Kosta Stojilkovic …

Wilkinson Walsh Wins Another Decisive Victory for Bayer in Xarelto Trial

Wilkinson Walsh’s Brian Stekloff Led the Team to Its Fourth Xarelto Win Washington, D.C. – Wilkinson Walsh, led by Founding Partner Brian Stekloff, won the second state-court bellwether trial over the blood-thinner Xarelto when the jury rejected claims against Bayer AG and Johnson & Johnson subsidiary Janssen Pharmaceuticals. Wilkinson Walsh Partners Lori Alvino McGill and Jeremy Barber also served as counsel for Bayer in the trial. The plaintiff in the Russell case alleged that Bayer and Janssen were liable for claims that the Xarelto label did not adequately instruct doctors on the risks of bleeding associated with the anticoagulant Xarelto. According to Law360, the Philadelphia jury “rejected claims that warnings labels for the … drug left out key information about the increased risk the drug posed when combined with antiplatelet medications.” Previously, Wilkinson Walsh secured two full defense verdicts for Bayer in similar cases in the federal multi-district litigation in …

Wilkinson Walsh Wins Victory for Bayer in First State-Court Xarelto Trial

WASHINGTON – On January 9, 2018, Wilkinson Walsh, led by Founding Partners Beth Wilkinson and Alexandra Walsh, won the first state-court bellwether trial over the blood-thinner Xarelto when the trial court entered judgment for Bayer and Janssen notwithstanding a jury verdict in favor of the plaintiff.  Wilkinson and Wilkinson Walsh had previously secured two full defense verdicts for Bayer in similar cases in the federal multi-district litigation in Louisiana. In December 2017, a jury in the Philadelphia Court of Common Pleas awarded nearly $28 million to plaintiff Lynn Hartman in a lawsuit that alleged that Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals were liable for claims that the Xarelto label did not adequately instruct doctors on the risks of bleeding associated with the anticoagulant Xarelto.  Bayer and Janssen then filed motions for judgment notwithstanding the verdict and a new trial.  The motions raised two key points (among many others).  …

Pro Bono Asylum Victory for Wilkinson Walsh

Wilkinson Walsh celebrates an asylum victory today for a sixteen-year old client fleeing persecution in Honduras. Our client suffered persecution in Honduras after his father, a member of a local taxi driver’s cooperative, defied a powerful international gang by refusing to make extortion payments. The gang stalked, threatened, and attempted to kidnap our client from school. Associate Max Warren led the case under the supervision of partner Brian Stekloff. Associates Norman Pentelovitch, Cali Cope-Kasten, and Meg Loftus, paralegal Youlan Xiu, and assistant Kat Phillips assisted with the case. The team worked in collaboration Human Rights First, a non-profit international human rights organization. We are proud of our client for the enormous bravery he has demonstrated in the face of adversity, and know he will be a model citizen in the United States.